Literature DB >> 26590147

Effect of bacillus Calmette-Guérin vaccination on CD4+Foxp3+ T cells during acquired immune response to Mycobacterium tuberculosis infection.

Marcela I Henao-Tamayo1, Andres Obregón-Henao2, Kimberly Arnett2, Crystal A Shanley2, Brendan Podell2, Ian M Orme2, Diane J Ordway2.   

Abstract

Increasing information has shown that many newly emerging strains of Mycobacterium tuberculosis, including the highly prevalent and troublesome Beijing family of strains, can potently induce the emergence of Foxp3(+)CD4 Tregs Although the significance of this is still not fully understood, we have previously provided evidence that the emergence of this population can significantly ablate the protective effect of BCG vaccination, causing progressive fatal disease in the mouse model. However, whether the purpose of this response is to control inflammation or to directly dampen the acquired immune response is still unclear. In the present study, we have shown, using both cell depletion and adoptive transfer strategies, that Tregs can have either properties. Cell depletion resulted in a rapid, but transient, decrease in the lung bacterial load, suggesting release or temporary re-expansion of effector immunity. Transfer of Tregs into Rag2(-/-)or marked congenic mice worsened the disease course and depressed cellular influx of effector T cells into the lungs. Tregs from infected donors seemed to preferentially depress the inflammatory response and granulocytic influx. In contrast, those from BCG-vaccinated and then challenged donors seemed more focused on depression of acquired immunity. These qualitative differences might be related to increasing knowledge reflecting the plasticity of the Treg response. © Society for Leukocyte Biology.

Entities:  

Keywords:  BCG vaccination; Tregs; inflammation

Mesh:

Year:  2015        PMID: 26590147      PMCID: PMC4787291          DOI: 10.1189/jlb.4A0614-308RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  51 in total

1.  Memory T lymphocytes generated by Mycobacterium bovis BCG vaccination reside within a CD4 CD44lo CD62 ligand(hi) population.

Authors:  Andre Kipnis; Scott Irwin; Angelo A Izzo; Randall J Basaraba; Ian M Orme
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

2.  Cutting Edge: Regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis.

Authors:  Mischo Kursar; Markus Koch; Hans-Willi Mittrücker; Geraldine Nouailles; Kerstin Bonhagen; Thomas Kamradt; Stefan H E Kaufmann
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

3.  Low-dose aerosol infection model for testing drugs for efficacy against Mycobacterium tuberculosis.

Authors:  B P Kelly; S K Furney; M T Jessen; I M Orme
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

Review 4.  CD4(+) regulatory T cells in autoimmunity and allergy.

Authors:  Maria A Curotto de Lafaille; Juan J Lafaille
Journal:  Curr Opin Immunol       Date:  2002-12       Impact factor: 7.486

5.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

6.  NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis.

Authors:  Carl G Feng; Mallika Kaviratne; Antonio Gigliotti Rothfuchs; Allen Cheever; Sara Hieny; Howard A Young; Thomas A Wynn; Alan Sher
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

7.  Inactivation of CD4+ CD25+ regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen load.

Authors:  Kylie M Quinn; Rebecca S McHugh; Fenella J Rich; Lisa M Goldsack; Geoffrey W de Lisle; Bryce M Buddle; Brett Delahunt; Joanna R Kirman
Journal:  Immunol Cell Biol       Date:  2006-07-20       Impact factor: 5.126

8.  Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.

Authors:  T Takahashi; Y Kuniyasu; M Toda; N Sakaguchi; M Itoh; M Iwata; J Shimizu; S Sakaguchi
Journal:  Int Immunol       Date:  1998-12       Impact factor: 4.823

9.  Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice.

Authors:  D J Ordway; M G Sonnenberg; S A Donahue; J T Belisle; I M Orme
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

10.  Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity.

Authors:  Alissa A Chackerian; Jennifer M Alt; Thushara V Perera; Christopher C Dascher; Samuel M Behar
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more
  4 in total

Review 1.  Adjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate Vaccination.

Authors:  Lakshmi Jayashankar; Richard Hafner
Journal:  Front Immunol       Date:  2016-12-16       Impact factor: 7.561

2.  Biology of clinical strains of Mycobacterium tuberculosis with varying levels of transmission.

Authors:  Crystal A Shanley; Marcela I Henao-Tamayo; Chand Bipin; Raja Mugasimangalam; Deepshika Verma; Diane J Ordway; Elizabeth M Streicher; Ian M Orme
Journal:  Tuberculosis (Edinb)       Date:  2018-02-09       Impact factor: 3.131

Review 3.  Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions.

Authors:  Deepshikha Verma; Edward D Chan; Diane J Ordway
Journal:  Vaccines (Basel)       Date:  2020-11-16

4.  Increase of CD4+CD25highFoxP3+ cells impairs in vitro human microbicidal activity against Mycobacterium tuberculosis during latent and acute pulmonary tuberculosis.

Authors:  Lorenzzo Lyrio Stringari; Luciana Polaco Covre; Flávia Dias Coelho da Silva; Vivian Leite de Oliveira; Maria Carolina Campana; David Jamil Hadad; Moisés Palaci; Padmini Salgame; Reynaldo Dietze; Daniel Cláudio de Oliveira Gomes; Rodrigo Ribeiro-Rodrigues
Journal:  PLoS Negl Trop Dis       Date:  2021-07-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.